chr6-137158386-A-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052962.3(IL22RA2):c.158T>A(p.Leu53His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000626 in 1,614,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052962.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IL22RA2 | NM_052962.3 | c.158T>A | p.Leu53His | missense_variant | 3/7 | ENST00000296980.7 | |
IL22RA2 | NM_181309.2 | c.158T>A | p.Leu53His | missense_variant | 3/6 | ||
IL22RA2 | NM_181310.2 | c.158T>A | p.Leu53His | missense_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IL22RA2 | ENST00000296980.7 | c.158T>A | p.Leu53His | missense_variant | 3/7 | 1 | NM_052962.3 | ||
IL22RA2 | ENST00000349184.9 | c.158T>A | p.Leu53His | missense_variant | 3/6 | 1 | P1 | ||
IL22RA2 | ENST00000339602.3 | c.158T>A | p.Leu53His | missense_variant | 3/5 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251160Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135730
GnomAD4 exome AF: 0.0000657 AC: 96AN: 1461846Hom.: 0 Cov.: 31 AF XY: 0.0000633 AC XY: 46AN XY: 727228
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 27, 2023 | The c.158T>A (p.L53H) alteration is located in exon 3 (coding exon 2) of the IL22RA2 gene. This alteration results from a T to A substitution at nucleotide position 158, causing the leucine (L) at amino acid position 53 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at